Abstract:The biological aging of mesenchymal stem cells is proposed to contribute to the development of a range of musculoskeletal and systemic diseases associated with older adults, such as osteoporosis, sarcopenia, and frailty. Despite this, little is understood about the specific mechanisms which drive this stem cell exhaustion, with most studies evaluating indirect effects of other aging changes, such as DNA damage, senescence, and inflammaging. In this study, we assess the transcriptomic and proteomic changes in three different populations of mesenchymal progenitor cells from older (50-70 years) and younger (20-40 years) individuals to uncover potential mechanisms driving stem cell exhaustion in mesenchymal tissues. To do this, we harvested primary bone marrow mesenchymal stem and progenitor cells (MPCs), circulating osteoprogenitors (COP), and adipose-derived stem cells (ADSCs) from younger and older donors, with an equal number of samples from males and females. These samples underwent RNA sequencing and label-free proteomic analysis, comparing the younger samples to the older ones. There was a distinct transcriptomic phenotype associated with the pooled older stem cells, indicative of suppressed proliferation and differentiation; however, there was no consistent change in the proteome of the cells. Older MPCs had a distinct phenotype in both the transcriptome and proteome, again consistent with altered differentiation and proliferation, but also a pro-inflammatory immune shift in older adults. COP cells showed a strong transcriptomic shift to pro-inflammatory signaling but no consistent proteomic phenotype. Similarly, ADSCs displayed transcriptomic shift in physiologies associated with cell migration, adherence, and immune activation, but no consistent proteomic change with age. These results show that there are underlying transcriptomic changes with stem cell aging that likely contribute to a decline in tissue regeneration; however, contextual factors such as the microenvironment and general health status also have a strong role in this.

Osteogenesis and aging: lessons from mesenchymal stem cells

Age-related Changes in Bone Marrow Mesenchymal Stromal Cells

Mesenchymal Stem Cell Aging: Mechanisms and Influences on Skeletal and Non-Skeletal Tissues

Senescence of skeletal stem cells and their contribution to age-related bone loss

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Rejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging

Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting

Bone Aging, Cellular Senescence, and Osteoporosis

Aging and Bone Metabolism

Functional and Molecular Changes of Mscs in Aging

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies

Mesenchymal Stem Cell-Based Cartilage Regeneration Approach and Cell Senescence: Can We Manipulate Cell Aging and Function?

Regulatory cellular and molecular networks in the bone microenvironment during aging

Microenvironmental Views on Mesenchymal Stem Cell Differentiation in Aging

Senile Osteoporosis: the Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells

Inflammaging, Epigenetic Damage, Mitochondrial Dysfunctions, and Macrophage Alterations are the Main Missing Pieces in the Complex Mosaic of Stem Cell Physiology

A Mesenchymal stem cell Aging Framework, from Mechanisms to Strategies

Differential responses to aging amongst the transcriptome and proteome of mesenchymal progenitor populations

Epigenetic Regulation in Mesenchymal Stem Cell Aging and Differentiation and Osteoporosis

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing